Metropolitan Life Insurance Company (MetLife)’s Neumora Therapeutics NMRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-921	Closed	-$12.7K	–	1382
2024 Q1	$12.7K	Hold	921	–	–	﹤0.01%	2045
2023 Q4	$15.7K	Buy	+921	New	+$15.7K	﹤0.01%	2020